Evidence map›Paper›PMID 35773570›Full record

ArticleClinical journal of gastroenterology2022

A rare case of fibrohistiocytic hepatic inflammatory pseudotumor with cholecystocholangitis showing positive IgG4 staining.

Ai Miyagi, Daisaku Fujimoto, Akina Yoshikawa, Seiko Okushi, Junko Miyagi, Ryosuke Matsumoto, Shinya Ogata, Yoshiaki Bando, Hirohisa Ogawa, Toshihito Tanahashi

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Application ofFrontiers in oncology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ai MiyagiDepartment of Internal Medicine, Local Incorporated Administrative Agency, Tokushima Prefecture Naruto Hospital, 32 Kurosaki Aza Kotani Muya-cho, Naruto, Tokushima, 772‑8503, Japan.
Daisaku FujimotoDepartment of Internal Medicine, Local Incorporated Administrative Agency, Tokushima Prefecture Naruto Hospital, 32 Kurosaki Aza Kotani Muya-cho, Naruto, Tokushima, 772‑8503, Japan.
Akina YoshikawaDepartment of Internal Medicine, Local Incorporated Administrative Agency, Tokushima Prefecture Naruto Hospital, 32 Kurosaki Aza Kotani Muya-cho, Naruto, Tokushima, 772‑8503, Japan.
Seiko OkushiDepartment of Internal Medicine, Local Incorporated Administrative Agency, Tokushima Prefecture Naruto Hospital, 32 Kurosaki Aza Kotani Muya-cho, Naruto, Tokushima, 772‑8503, Japan.
Junko MiyagiDepartment of Internal Medicine, Local Incorporated Administrative Agency, Tokushima Prefecture Naruto Hospital, 32 Kurosaki Aza Kotani Muya-cho, Naruto, Tokushima, 772‑8503, Japan.
Ryosuke MatsumotoDepartment of Surgery, Local Incorporated Administrative Agency, Tokushima Prefecture Naruto Hospital, 32 Kurosaki Aza Kotani Muya-cho, Naruto, Tokushima, 772‑8503, Japan.
Shinya OgataDepartment of Surgery, Local Incorporated Administrative Agency, Tokushima Prefecture Naruto Hospital, 32 Kurosaki Aza Kotani Muya-cho, Naruto, Tokushima, 772‑8503, Japan.
Yoshiaki BandoDepartment of Surgery, Local Incorporated Administrative Agency, Tokushima Prefecture Naruto Hospital, 32 Kurosaki Aza Kotani Muya-cho, Naruto, Tokushima, 772‑8503, Japan.
Hirohisa OgawaDepartment of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15, Kuramoto-cho, Tokushima, 770-8503, Japan.
Toshihito TanahashiDepartment of Internal Medicine, Local Incorporated Administrative Agency, Tokushima Prefecture Naruto Hospital, 32 Kurosaki Aza Kotani Muya-cho, Naruto, Tokushima, 772‑8503, Japan. tanahashi@kuh.biglobe.ne.jp.ORCID http://orcid.org/0000-0002-9308-210X
Naruto, Tokushima Prefecture hospital · JPTokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory pseudotumor (IPT) is a rare benign mass characterized by infiltration of inflammatory cells and proliferation of fibrous tissues. Consistent with increasing knowledge about IgG4-related disease (RD), it has been implicated in the etiology of hepatic IPT, which is pathologically classified into two categories with respect to the proportion of IgG4-positive plasma cells: fibrohistiocytic- and lymphoplasmacytic-type. A 66-year-old man was admitted for treatment of cholecystocholangitis. Incidentally, abdominal computed tomography (CT) revealed an ambiguous low-density mass within segment 4 (S4) of the liver. Magnetic resonance imaging (MRI) showed the typical images of hepatic IPT within S4. Together with CT and MRI imaging, we suspected hepatic IPT, and had the opportunity to biopsy the S4 lesion during surgery for cholecystitis. Histopathological examination of liver tissue showed diffuse fibrous tissues, dense lymphoplasmacytic infiltration, and obliterative phlebitis with no evidence of malignancy. Despite infiltration of IgG4-positive plasma cells, these histological findings corresponded with fibrohistiocytic-type hepatic IPT. Similarly, in the resected gallbladder, relatively abundant IgG4-positive cells were observed, but not entirely consistent with IgG4-RD criteria. Although IgG4 immunostaining can be useful for the classification of hepatic IPT, the present histological tissues were borderline condition defined by IgG4-RD criteria. This rare case of hepatic IPT suggests a future focus on the borderline histological features of IgG4-RD.

Indexed as

Granuloma, Plasma CellImmunoglobulin G4-Related DiseaseAgedHumansImmunoglobulin GImmunohistochemistryMaleStaining and LabelingImmunoglobulin GCholecystocholangitisFibrohistiocytic-typeHepatic inflammatory pseudotumorIgG4-related diseaseLymphoplasmacytic-type

Identifiers

PMID35773570
OpenAlexW4283732070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.